ADRENAL METASTASES OF RENAL CELL CARCINOMA WITH INTRAVENOUS TUMOR THROMBI OF THE INFERIOR VENA CAVA (two case repor ts with literature review)

Authors

  • Shchukin D. V. Kharkiv National Medical University, Kharkiv, Ukraine; MHI «V. I. Shapoval Regional Medical Clinical Center of Urology and Nephrology», Kharkiv, Ukraine
  • Lesovoy V. N. Kharkiv National Medical University, Kharkiv, Ukraine; MHI «V. I. Shapoval Regional Medical Clinical Center of Urology and Nephrology», Kharkiv, Ukraine
  • Balarabe U. M. Kharkiv National Medical University, Kharkiv, Ukraine
  • Khareba G. G. Kharkiv National Medical University, Kharkiv, Ukraine; MHI «V. I. Shapoval Regional Medical Clinical Center of Urology and Nephrology», Kharkiv, Ukraine
  • Antonian I. M. Kharkiv medical academy of postgraduate education, Kharkiv, Ukraine
  • Kopytsya M. P. L. T. Malaya National Institute of Therapy of NAMS of Ukraine, Kharkiv, Ukraine
  • Harahatyi A. I. Kharkiv National Medical University, Kharkiv, Ukraine; MHI «V. I. Shapoval Regional Medical Clinical Center of Urology and Nephrology», Kharkiv, Ukraine
  • Shus A. V. Kharkiv medical academy of postgraduate education, Kharkiv, Ukraine

DOI:

https://doi.org/10.21856/j-PEP.2020.3.16

Keywords:

renal cell carcinoma, adrenal metastases, intravenous invasion, tumor thrombus

Abstract

Intrvenous extension is one of the features of neoplastic process and is very characteristic for tumors of the kidneys and adrenal glands. However, reports about the penetration of adrenal metastases into the venous system are extremely rare. We have presented two case reports on intravenous extension of renal cell carcinoma adrenal metastases. One of them for the first time in worldwide literature presents intravenous extension of synchronous bilateral adrenal metastases RCC into inferior vena cava and left renal vein. The patient underwent bilateral adrenalectomy with the use of hormone replacement therapy and targeted therapy with pazopanib. MDCT after 2 and 6 months did not show tumor progression. Lungs metastases are reduced in size or remained unchanged. The patient does not complain. Blood pressure 110/70 mm Hg. Symptoms of Addison's disease are absent. In the second case, there was a metachronic contralateral metastasis of RCC, which penetrated through the right adrenal vein into the subhepatic section of the inferior vena cava. The patient underwent a right-sided adrenalectomy with thrombectomy. After 6 months multiple pulmonary metastases were identified. Pazopanib therapy has initiated. Three months later, tumor progression was revealed. The patient died after 5 months (14 months after surgery) from tumor intoxication. Although these cases are extremely rare (7 cases in the world literature), it is necessary to take into account possibility of presence of venous tumor thrombi with adrenal metastases. The incidence of this phenomenon of RCC is in the second place after hepatocellular carcinoma (15 cases). Organ-sparing surgical technique in these patients is not feasible. Targeted therapy along with hormone replacement therapy was not accompanied by increased side effects or exacerbation of adrenal insufficiency after removal of both adrenal glands.

References

Siemer S, Lehmann J, Kamradt J, et al. J Urol 2004; 171: 2155-2159. https://doi.org/10.1097/01.ju.0000125340.84492.a7.

Antonelli A, Cozzoli A, Simeone C, et al. BJU Int 2006; 97(3): 505-508.

Lau WK, Zincke H, Lohse CM, et al. BJU Int 2003; 91: 775-779. https://doi.org/10.1046/j.1464-410X.2003.04237.x.

Weight CJ, Kim SP, Lohse CM, et al. Eur Urol 2011; 60(3): 458-464.

Koutalellis GE, Felekouras E, Evangelou C, et al. Cases J 2009; 2: 7298. https://doi.org/10.4076/1757-1626-2-7298.

Yu CC, Huang JK, Tzeng WS, et al. Eur Urol 1992; 22: 335-338

Selli C, Carini M, Barbanti G, et al. J Urol 1987; 137: 480-482.

Schomer NS, Mohler JL. J Urol 1995; 153: 1196-1198. https://doi.org/10.1016/S0022-5347(01)67550-5.

Öztürk Н. Oncology 2015; 9: 1897-1901. https://doi.org/10.3892/ol.2015.2915.

Tanaka A, Takeda R, Mukaihara S, et al. J Gastroenterol 2002; 37: 220-228. https://doi.org/10.1007/s005350200025.

Takahashi K, Furuse M, Hanaoka H, et al. J Comput Tomogr 2000; 24: 557- 561.

Hoehn W, Hermanek P. Eur Urol 1983; 9.

Lucon AM, Machado MCC, Pereira MAA. BJU Int 2004; 94(1): 70-73. https://doi.org/10.1111/j.1464-410X.2004.04903.x

von Knobloch R, Hegele A, Kälble T, Hofmann R. Scand J Urol Nephrol 2000; 34(2): 109-113. https://doi.org/10.1080/003655900750016715.

Piotrowicz S, Muśko N, Kozikowski M, et al. J Ultrason 2015; 15(63): 438-442. https://doi.org/10.15557/JoU.2015.0041.

Pereverzev AS, Andreev AA. Vestn Khir Im I I Grek 1990; 144(6): 53-55.

Rosenblatt GS, Takesita K, Fuchs GJ, et al. Urology 2009; 74(2): 290-291. https://doi.org/10.1016/j.urology.2009.02.055.

Ploumidis A, Spinoit AF,2, De Naeyer G, et al. Int J Med Robot 2015; 11(4): 413-417. https://doi.org/10.1002/rcs.1641.

Musholt ThJ. European Surg 2003; 35(2): 97-101. https://doi.org/10.1046/j.1682-4016.2003.03043.

Hedican SP, Marshall FF. J Urol 1997; 158: 2056-2061.

Lucon AM, Pereira MAA, Mendonca BB, et al. J Urol 1997; 157: 1208-1212.

Lam KY, Lo CY. Clin Endocrinol (Oxf) 2002; 56(1): 95-101. https://doi.org/10.1046/j.0300-0664.2001.01435.x.

Lo CY, van Heerden JA, Soreide JA, et al. Br J Surg 1996; 83(4): 528-531. https://doi.org/10.1002/bjs.1800830432.

Bensalah K, Guille F, De la Taille A, et al. Eur Urol 2005; 4: 52.

Blute ML, Leibovich BC, Lohse ChM, et al. BJU Int 2004; 94: 33-41. https://doi.org/10.1111/j.1464-410X.2004.04897.x.

Strugnell M, Gibson M, Hopkins R. BJR 2005; 78: 65-67. https://doi.org/10.1259/bjr/68967544.

Shhukin DV, Iljuhin JuA. Hirurgija opuholevyh trombov nizhnej poloj veny pri rake pochki, Belgorod, 2007: 196 p.

Yachida S, Fukushima N, Kanai Y, et al. Jap J Clin Oncol 2002; 32: 315-317. https://doi.org/10.1093/jjco/hyf066.

Ueda K, Ohory M, Taka J, Kusano M. Surg Todey 2002; 32: 458-461. https://doi.org/10.1007/s005950200076.

Roslin JJ, Kuchenbecker S, Longmire WP, Tompkins RK. Arch Surg 1984; 119: 1312-1315. https://doi.org/10.1001/archsurg.1984.01390230078019.

Takada K, Nakamura K, Usuki N, et al. Rinsho Hoshasen 1989; 34(12): 1529-1532.

Sakamoto Y, Kubota K, Mori M, et al. Hepatogastroenterology 1999; 46(26): 1036-1041.

Morimoto T, Honda G, Oh Y, et al. J Gastroenterol 1999; 34(1): 132-137. https://doi.org/10.1007/s005350050229.

Shimahara Y, Shibata T, Morimoto T, et al. Surg Today 1999; 29(12): 1273-1276.

Momoi H, Shimahara Y, Terajima H, et al. Surg Today 2002; 32(12): 1035-1041. https://doi.org/10.1007/s005950200210.

Paparel P, Tatou E, Krause D, et al. Prog Urol 2004; 14(2): 203-204.

Ben Abid S, Gharbi L, Arfa MN, et al. J Chir (Paris) 2005; 142(5): 311-312.

Fernández Sarabia MT, Rodríguez García JM, Cardenal Escarcena A, et al. Clin Transl Oncol 2008; 10(11): 761-763. https://doi.org/10.1007/s12094-008-0284-8.

Wakayama K, Kamiyama T, Yokoo H, et al. World J Surg Oncol 2013; 5(11): 259. https://doi.org/10.1186/1477-7819-11-259.

Hiroyuki Tokue, Azusa Tokue, Yoshito Tsushima. J Ovarian Res 2014; 7: 5. https://doi.org/10.1186/1757-2215-7-5.

Yang ST, Liao YH, Lin WC, et al. J Obstet Gynaecol 2014; 34(2): 206-207. https://doi.org/10.3109/01443615.2013.841657.

Filippi L, Sardella B, Ciorra A, et al. Cancer Biother Radiopharm 2014; 29(5): 189-192. https://doi.org/10.1089/cbr.2014.1612.

Vishnevskiĭ AV, Andreĭtseva OI, Kharazov AF, et al. Khirurgiia (Mosk) 2015; 1: 68-72.

von Knobloch R, Schrader AJ, Walthers EM, Hofmann R. Urology 2009; 73(2): 333-336. https://doi.org/10.1016/j.urology.2008.09.037.

Rosenthal FD, Davies MK, Burden AC. Br Med J 1978; 1: 1591-1592. https://doi.org/10.1136/bmj.1.6127.1591-a

Schomer NS, Mohler JL. J Urol 1995; 153: 1196-1198.

Downloads

Published

2020-08-31

How to Cite

Shchukin, D. V., Lesovoy, V. N., Balarabe, U. M., Khareba, G. G., Antonian, I. M., Kopytsya, M. P., Harahatyi, A. I., & Shus, A. V. (2020). ADRENAL METASTASES OF RENAL CELL CARCINOMA WITH INTRAVENOUS TUMOR THROMBI OF THE INFERIOR VENA CAVA (two case repor ts with literature review). Problems of Endocrine Pathology, 73(3), 126-135. https://doi.org/10.21856/j-PEP.2020.3.16